L. Grodzińska

Double-blind controlled trial of the therapeutic effects of prostacyclin in patients with completed ischaemic stroke.

A. Dembińska-kieć, R. Gryglewski, E. Kostka-Trąbka, 1985, Stroke.

Prostacyclin and blood glucose levels in humans and rabbits.

A. Dembińska-kieć, E. Kostka-Trąbka, K. Bieroń, 1981, Prostaglandins.

Prostacyclin and molsidomine synergise in their fibrinolytic and anti-platelet actions in patients with peripheral arterial disease.

R. Gryglewski, E. Kostka-Trąbka, K. Bieroń, 1993, Wiener klinische Wochenschrift.

Increased platelet activity after termination of prostacyclin infusion into man.

A. Dembińska-kieć, E. Kostka-Trąbka, K. Bieroń, 1981, Prostaglandins.

Effect of prostacyclin (PGI2) on platelets and fibrinolytic activity in patients with arteriosclerosis obliterans.

A. Dembińska-kieć, E. Kostka-Trąbka, K. Bieroń, 1982, Pharmacological research communications.

L-arginine--substrate for no synthesis--its beneficial effects in therapy of patients with peripheral arterial disease: comparison with placebo-preliminary results.

R. Gryglewski, E. Kostka-Trąbka, K. Bieroń, 1996, Acta Physiologica Hungarica.

Treatment with L-arginine is likely to stimulate generation of nitric oxide in patients with peripheral arterial obstructive disease.

R. Gryglewski, R. Korbut, E. Kostka-Trąbka, 1996, Wiener klinische Wochenschrift.

[Prostacyclin in treatment of peripheral vascular disease of lower extremities (author's transl)].

A. Szczeklik, A. Dembińska-kieć, R. Gryglewski, 1980, Przeglad lekarski.